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Abstract.  We examined the roles of the extracellular 
domains of a gap junction protein and a cell adhesion 
molecule in gap junction and adherens junction forma- 
tion by altering cell interactions  with antibody Fab 
fragments.  Using immunoblotting  and immunocyto- 
chemistry we demonstrated that Novikoff cells con- 
tained the gap junction protein,  cormexin43  (Cx43), 
and the cell adhesion molecule, A-CAM (N-cadherin). 
Cells were dissociated in EDTA, allowed to recover, 
and reaggregated for 60 min in media containing  Fab 
fragments prepared from a number of antibodies.  We 
observed no cell-cell dye transfer 4  min after micro- 
injection in 90% of the cell pairs treated with Fab frag- 
ments of antibodies for the first or second extracellular 
domain of Cx43, the second extracellular domain of 
connexin32  (Cx32) or A-CAM.  Cell-cell dye transfer 
was detected within 30 s in cell pairs treated with con- 
trol Fab fragments (pre-immune serum,  antibodies to 
the rat major histocompatibility complex or the amino 
or carboxyl termini of Cx43).  We observed no gap 
junctions by freeze-fracture EM and no adherens junc- 
tions by thin section EM between cells treated with the 
Fab fragments that blocked cell-cell dye transfer.  Gap 
junctions were found on •50%  of the cells in control 
samples using freeze-fracture EM.  We demonstrated 
with reaggregated Novikoff cells that:  (a) functional 
interactions  of the extracellular domains of the con- 
nexins were necessary for the formation of gap junc- 
tion channels;  (b) cell interactions mediated by A-CAM 
were required for gap junction assembly; and  (c) Fab 
fragments of antibodies for A-CAM or connexin extra- 
cellular domains blocked adherens junction formation. 
AP junctions are composed of channels  (connexons) 
that  provide intercytoplasmic pathways for the dif- 
fusion of small  molecules (3,  6).  Each channel  is 
thought to be formed by six similar or identical proteins,  the 
connexins (3, 5, 6). The connexins (Cx)~ comprise a family 
of proteins with sequence homology and a similar predicted 
membrane topology (4, 5, 9,  16,  17, 21, 34, 37, 38, 54, 56, 
57). The generally accepted topological model for the Cxs 
has four transmembrane segments  with the amino and car- 
boxyl termini located on the cytoplasmic side of the mem- 
brane.  The transmembrane  and  extracellular  domains are 
conserved while the cytoplasmic domains,  except for the 
short  amino  terminus,  are  structurally  diverse.  The  two 
highly conserved extracellular  domains may be important 
for the recognition and binding of Cxs on the surfaces of ad- 
jacent cells.  Therefore,  the extracellular  domains  may play 
a key role in gap junction assembly and the establishment of 
cell-cell communication. 
We report the first demonstration that Fab fragments of an- 
tibodies  for  the  extracellular  domains  of  Cxs  impeded 
cell-cell dye transfer and inhibited the assembly of gap junc- 
tion structures when added to the media bathing  the cells. 
Our results  indicated  that functional  interactions  of the ex- 
tracellular Cx domains were necessary for the formation  of 
gap junction channels.  We also demonstrated that cell inter- 
actions mediated by A-CAM (N-cadherin)  were required for 
gap junction assembly between reaggregated  Novikoff cells. 
We observed that  adherens junction  formation  was  in- 
hibited by treatment of the cells with Fab fragments  of anti- 
bodies for the extracellular  domains  of Cxs  or  A-CAM. 
Adherens junctions are cell-cell membrane specializations 
that have protein components associated with cadherins  ex- 
tracellularly (50) and with actin filaments on the cytoplasmic 
surface (47, 48).  Anti-A-CAM Fab fragments  have previ- 
ously been  reported  to  alter  adherens junction  assembly 
(49).  The inhibition  of adherens junction assembly by the 
Fab fragments of antibodies for the Cx extracellular  domains 
was unexpected. 
Dr. Lairds current address is Department of Anatomy, McGill University, 
Montreal, Quebec, Canada. 
1. Abbreviations used in this paper: Cx, connexin; MHC, major histocom- 
patibility complex; MIP, main intrinsic protein; N-CAM, neural cell adhe- 
sion molecule. 
Materials and Methods 
lmmunoblot Analysis 
We isolated Novikoff plasma membranes by a dextran-polyethylene  glycol 
phase separation method (36). The membranes were kept at 4~  in buffer 
containing 10 mM EDTA (Sigma Chemical Co., St.  Louis,  MO), 2 mM 
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Biochewicals, Indianapolis, IN), and 1 #g/ml leupeptin (Boefiringer Mann- 
helm Biochewicals) during the entire isolation procedure.  The membranes 
were washed and proteins separated on  10%  SDS-polyacrylamide gels 
(26).  The proteins were transferred to nitrocellulose paper (Biotrace  NT; 
Gelnmn Sciences,  Inc., Ann Arbor, MI). The blots were cut into strips, 
blocked in 3% BSA in TBS (25 mM Tris-HCl, 150 mM NaCl, pH 7.4), 
and probed with the different antibodies.  Strips of the transfers were in- 
cubated with: Ca) a rabbit polyclonal  site-directed  antibody for the amino 
terminus of Cx43 (AT-2, see Fig.  1) at 0.5/~g protein/ml that was kindly 
provided by B. Yancey (California State Polytechnic  University,  Pomona, 
CA) (54); (b) an affinity purified rabbit polyclonal antibody for the first ex- 
tracellular domain of Cx43 (EL-46,  see Fig. 1) at 5 #g/ml (27); (c) an affin- 
ity purified rabbit polyclonai antibody for the second extracellular domain 
of Cx43 (EL-186, see Fig. 1) at 0.5 #g/ml (27); (d) a rabbit polyclonal anti- 
body for the second extracellular domain of Cx32,  residues  164-189 of 
Cx32 (see Fig. 1), at 1 tzg/ml that was kindly provided by D. A. Goodenongh 
(Harvard University, Cambridge, MA) (17); (e) an affinity purified antibody 
for the earboxyl terminus of Cx43 (27) at 0.5 sg/ml (CT-360, see Fig.  1); 
(f) pre-immune serum for the antibody for the second extracellular domain 
of Cx32 at 1 t~g/ml that was kindly provided by D. A. Goodanough (17); 
(g) pre-immane serum as a control for the rabbit polyclonal  antibodies or 
mouse ascites as a control for the mouse mAb; (h) a mouse mAb for the 
cell adhesion molecule,  A-CAM,  at 1/~g/ml (Sigma Chemical  Co.) (49); 
(i) a mouse mAb for a rat major histocompatibility complex (MHC) at 1 
/~g/ml (Chewicon International Inc., Temecula, CA); and (j) immune rabbit 
serum for the main intrinsic protein of the lens (MIP).  The blots were 
washed and reacted with either an alkaline phosphatase-labeled anti-rabbit 
IgG or an alkaline phosphatase-labeled anti-mouse IgG (Promega Biotec, 
Madison, WI). The alkaline phosphatase was developed  with 5-bromo-4- 
chloro-3-indolyl-phosphate  and nitroblue tetrazolium (Kirkegaard & Perry 
Laboratories, Gaithersburg, MD). 
Alkaline Phosphatase Treatment 
The Novikoff membranes were washed three times (50 mM Tris-HC1,  10 
mM MgCl2,  150 mM NaCl) and treated with 20 U/wi of molecular biol- 
ogy grade alkaline phosphatase (3000 U/rag; Boehringer Mannheim Bio- 
chemicals) in buffer containing 0.1% Triton X-100, and 0.05% SDS for 4 h 
at 37~  (35).  Protease inhibitors (2 mM PMSF,  1 /zg/ral pepstatin, and 
1 t~g/ml leupeptin) were present in all the solutions used for the alkaline 
phosphatase treatment. A concurrent sample was treated with alkaline phos- 
phatase in the presence of the alkaline phosphatase inhibitors, 2 mg/mi so- 
dium orthovanadate  (Sigma Chemical Co.),  10 mM EDTA,  and 10 mM 
NaH2PO4. Samples were then analyzed by SDS-PAGE (26). 
Immunofluorescence 
Indirect immunofluorescence  was performed on cells attached for 1 h to 
glass  Labtek chamber slides  coated  with Cell-Tak  (Biopolymers Inc., 
Farmington, CT) according to the manufacturer's instructions. The cells 
used for anti-Cx antibody labeling were fixed for 10 rain in 1% fresh para- 
formaldehyde,  permeabilized with 0.2% Triton X-100 for 10 rain, and then 
blocked and quenched in 3% BSA with 10 mM glycine in PBS (137 mM 
NaC1, 3 mM KC1, 10 mM phosphate, pH 7.4) for 30 rain. Cells used for 
anti-A-CAM  and anti-MHC labeling were fixed but remained unperme- 
abilized so that only the cell surface  was labeled.  The cells were reacted 
for 2 h at room temperature with nonimmune serum or antibodies for the 
amino or carboxyl termini of Cx43, anti-MHC, or anti-A-CAM. The sam- 
ples were washed and incubated for 1 h with goat anti-rabbit or goat anti- 
mouse  HI'C-labeled  antibodies  (Gibco/BRL,  Gaithersburg,  MD)  and 
viewed  with a  Zeiss fluorescence microscope (Carl Zeiss,  Oberkochen, 
Germany). 
Immunogold Labeling  for Transmission 
Electron Microscopy 
Pre-embedding Labeling. Isolated Novikoff cell membranes were washed 
in buffer (1% BSA, 0.05% NP-40, 5 mM EDTA, 0.9% NaCl, and 25 mM 
Tris base) and incubated for 1 h at room temperature in non-immune serum 
or with anti-Cx43 antibodies for either the amino or carboxyl termini. The 
membranes were washed and incubated with 10 nm gold-labeled anti-rabbit 
IgG (Janssen Life Sciences Products,  Piscataway, NJ) at a 1:50 dilution for 
1.5 h. The samples were fixed in 1.5% glntaraldehyde  with 0.25% tannic 
acid in 0.1 M cacodylate buffer. The membranes were treated for 1 h with 
osmium, dehydrated, and embedded in Epon/Araldite. 
Post-embedding Labeling. Cells were fixed in 1% paraformaldehyde  in 
$210 media for  I0  win and  embedded in  Lowicryl K4M at -30~  accord- 
ing to the manufacturer's  directions.  The K4M  was polymerized for  24 h 
under UV light.  Thin sections  were blocked in PBS with I% BSA for  30 
rain  and reacted  with non-immune serum or antibodies  for  the  second ex- 
tracellular  domain  of  Cx43 in  PBS (with  I% BSA, 0.1% Tween-20, and  0.1% 
Triton  X-100) for  2-3 h (41).  The sections  were washed and incubated  in 
I0 nm gold-labeled  anti-rabbit  IgG (Janssen  Life  Sciences  Products)  at  a 
1:20  dilution  for L5 h. The grids  were washed and stained  in 5% uranyl 
acetate  for 30 rain. 
Morphometric Analysis 
We examined thin sections of cell interfaces to evaluate the extent of cell 
apposition following the antibody Fab fragment treatments.  The regions of 
membrane-membrane contact  between  adjacent  cell  pairs  were  pho- 
tographed at a magnification of 10,000 and the micrographs were printed 
at a magnification of 75,000. We measured the membrane-membrane dis- 
tances between adjacent cell Fairs at multiple points along their interfaces 
to determine the extent of apposition as previously described (53). We also 
counted the number of adherens junctions present between the cell pairs. 
Fab Fragment Production 
Fab fragments from the different antibodies were prepared according to the 
manufacturer's instructions using a Pierce ImmunoPure Fab Preparation Kit 
(Pierce  Chemical Co., Rockford,  IL).  The antibody Fab fragments  were 
concentrated by centrifugation  through Centricon-30 filters (Amicon Corp., 
Danvers,  MA). The protein concentration of the Fab fragments  was mea- 
sured using the bicinchoninic  acid protein assay (Pierce Chemical Co.) with 
BSA as a standard. The papain digestion of the antibodies was checked by 
separation of the proteins on 13 % SDS-polyacrylarnide  gels which were 
then silver stained. A prominent band was observed at 55 kD (using non- 
reducing conditions) with little protein present elsewhere  in the gel (data 
not shown). 
Cell Dissociation, Recovery, and Reaggregation 
Novikoff cells were cultured as previously  reported (22, 33, 39).  Cells in 
logarithmic growth were centrifuged from standard growth media ($210 + 
10% newborn calf serum, Gibeo/BRL), resuspended in $210 media with 
10 mM EDTA at 6  x  105 cells/nil, and placed in a 37~  gyratory shaker 
incubator (200 rpm) for 15 win. The EDTA treatment was repeated once 
resulting in >95 % single cells. The cells were allowed to recover from the 
EDTA treatment in $210 media with 5 % newborn calf serum (Gibco/BRL) 
for 90 rain (39, 40).  Cells were settled onto 35-ram petri dishes (8  ￿  105 
cells per dish) for 60 rnin in media containing Fab fragments of the various 
antibodies. Three or more independent sets of experiments were performed 
with each treatment. Each experimental set was performed by the same per- 
son (R. Meyer) on coded samples and without knowledge of sample treat- 
ment. Each experimental set included pre-immune serum and at least one 
other control antibody treatment along with concurrent samples treated with 
the Fab fragments for the extracellular domains of the Cxs or A-CAM. 
Microinjection of Dye 
Dye injection  studies  were  performed to  evaluate  dye  permeability  between 
reaggregated  cells  that  had been settled  onto petri  dishes.  One cell  of  a  pair 
was microinjected  with a 4-ms pulse  of I% aqueous Lucifer  yellow CH 
(Sigma Chemical Co.) at 25 psi using a General Valve  picospritzer.  We 
monitored cell-cell  dye  transfer  for  each cell  pair  for  a  4-rain  period  after 
dye  injection  using  a  Zeiss  IM35 inverted  microscope (Carl  Zciss).  The  cell 
pairs  were recorded on videotapes  using a Dage SIT camera (Dage-MTI 
Inc., Wabash, IN), Panasonic video recorder and TV monitor, and on 
T-Max film  (Eastman Kodak Co., Rochester,  NY). 
Freeze-fracture and EM 
Cells were fixed in the petri dishes after dye microinjection by replacing 
the experimental media with media containing 2.5% glutaraldehyde.  The 
fixed cells were washed and used for freeze-fracture  or thin section EM. 
We  examined freeze-fracture  replicas of cell  interfaces which were 
defined as fractured membrane areas comprising at least 57/tin  2 and con- 
talning an indication of cell-ceU apposition  (39).  Cell interfaces were 
scored for the presence of one or more gap junctions or formation plaques. 
"Formation plaques" were  defined  as  specialized  membrane areas with 
clusters or arrays of 9-11-nm intramembranous particles (22, 33, 39). 
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Figure 1. A schematic representation of membrane topology of the 
polypeptide backbone of Cx43, as deduced from the eDNA se- 
quence (4). The striped regions represent the peptide sequences 
used to generate the site-directed polyclonal antibodies employed 
in this  study  (27, 54).  The anti-Cx32 antibody was  generated 
against a segment of Cx32 predicted to be part of the second extra- 
cellular domain (17). 
Results 
We used Novikoff cells as a model system to investigate the 
components involved in gap junction assembly. The Novikoff 
cell line was previously derived from a chemically induced 
rat liver tumor and adapted to growth in suspension culture. 
The cells are probably not a hepatocyte cell line but may be 
of Kupffer endothelial cell origin  (33).  Novikoff cells are 
readily dissociated without the use of proteases and when 
reaggregated form functional junctions over a time course of 
minutes (22, 39). 
lmmunoblot Analysis 
We used several affinity purified site-directed antibodies to 
Cx43  (Fig.  1)  to  characterize  a  gap  junction  protein  in 
Novikoff  plasma  membranes.  Membrane  proteins  were 
separated with SDS-PAGE and analyzed after transfer onto 
nitrocellulose paper.  The anti-Cx43 antibodies recognized 
bands with apparent molecular weights of  43 and 45 kD (Fig. 
2 A). Antibodies for the amino terminus of Cx43 (AT-2; Fig. 
2 A, lane/) also recognized bands of 29, 49, and 71 kD. We 
observed differences in the binding of the various anti-Cx43 
antibodies to the 43- and 45-kD proteins (Fig. 2 A). The anti- 
bodies for the first extracellular domain of Cx43  (EL-46; 
Fig. 2 A, lane 2) preferentially recognized the 45-kD protein. 
The antibodies for the second extracellular domain of Cx43 
(EL-186; Fig. 2 A, lane 3) recognized both the 43- and 45-kD 
proteins but reacted more intensely with the 43-kD protein 
band. The anti-Cx32 extracellular domain antibody (Fig. 2 
A, lane 4) and anti-Cx43 carboxyl terminus antibody (CT- 
360; Fig. 2 A, lane 5) recognized both bands equally. Pre- 
immune and non-immune serum (Fig. 2 A, lanes  6 and  7) 
showed no reactivity with Novikoff proteins. 
Novikoff plasma  membranes were treated with alkaline 
phosphatase  to  examine  whether  the  45-kD  protein  was 
phosphatase sensitive. The proteins were separated on SDS- 
polyacrylamide gels and reacted with the anti-Cx43 antibody 
for the carboxyl terminus after phosphatase treatment. The 
antibody detected only the 43-kD band (Fig. 2 B, lane 8) in 
alkaline phosphatase-treated samples but recognized both 
the 43- and 45-kD bands in membranes treated with alkaline 
phosphatase in the presence of alkaline phosphatase inhibi- 
tors (Fig. 2 B, lane 9). Our results suggest that the 45-kD 
band,  which was  sensitive to alkaline phosphatase,  was a 
Figure  2.  Immunoblots  of 
Novikoff cell membranes that 
were reacted with anti-Cx an- 
tibodies.  Plasma  membrane 
proteins  were  separated  on 
10% SDS-polyacrylamide  gels 
and analyzed after transfer to 
nitrocellulose  paper.  Incu- 
bation  with  several  affinity 
purified site-directed antibod- 
ies as well as preimmune se- 
rum was followed by reaction 
with an alkaline phosphatase 
anti-rabbit  IgG  according to 
standard  immunoblot  con- 
ditions.  (.4) Novikoff  mem- 
branes  probed  with:  lane  1, 
antibody for the amino termi- 
nus of Cx43 (AT-2); lane 2, 
antibody for the first extracel- 
lular  domain  of Cx43  (EL- 
46);  lane 3, antibody for the 
second  extracellular  domain 
(EL-186); lane 4, antibody for the second extracellular domain of Cx32; lane 5, antibody for the carboxyl terminus of Cx43 (CT-360); 
lane 6, preimmune serum for the anti-Cx32 extracellular domain antibody; lane 7, non-immune serum. (B) Novikoff membranes treated 
with alkaline phosphatase (lane 8) or alkaline phosphatase with orthovanadate and EDTA (lane 9). We probed the transferred proteins 
with the anti-Cx43 carboxyl terminus antibody (CT-360). Molecular weights are indicated in kD on the left of the figure. 
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(24, 27, 28,  35). 
Immunocytochemistry 
We used  different immunolabeling techniques to demon- 
strate labeling of the cells with the antibodies used in this 
study. Indirect immunofluorescence  was performed on para- 
formaldehyde fixed and detergent permeabilized Novikoff 
cells to examine labeling of the cell with antibodies made to 
the cytoplasmic domains of Cx43.  Negligible levels of im- 
munofluorescence staining were observed on cells treated 
with non-immune serum (Fig. 3 a). We observed discrete 
punctate immunolabeling at cell-cell interfaces on cells that 
had been treated with site-directed antibodies to the amino 
terminus (Fig. 3 b) and the carboxyl terminus of Cx43 (Fig. 
3 c). Punctate immunolabeling was absent from cell surfaces 
that were not closely apposed. The anti-Cx43 antibodies also 
reacted with perinuclear regions of the cells. 
Paraformaldehyde fixed but unpermeaWflized  cells were 
labeled with the anti-A-CAM (N-cadherin) and anti-MHC 
antibodies to examine their cell surface distribution. We ob- 
served  diffuse membrane  immunolabeling with  the  anti- 
A-CAM  and the anti-MHC  antibodies  (data  not shown). 
Negligible levels of immunofluorescence staining were ob- 
served on cells treated with mouse ascites fluid as a control 
for the mAb. 
Pre-embedding immunogold labeling and EM were used 
to localize the anti-Cx43 cytoplasmic domain antibodies to 
gap junctions in isolated Novikoff membranes (Fig. 4). We 
observed  few  gold  particles  in  thin  sections  of isolated 
Novikoff  gap junction membranes treated with non-immune 
serum (Fig. 4 a). However, strong immunogold labeling was 
observed on gap junction profiles treated with the anti-Cx43 
antibody for the carboxyl terminus  (Fig.  4  b)  or for the 
amino terminus (data not shown). 
An internal control for the specificity  of  anti-Cx antibodies 
was the absence of labeling on single membrane vesicles 
present in the Novikoff  membrane preparations. The isolated 
membranes layered when processed for immunogold label- 
ing such that single membrane vesicles banded in a  layer 
directly above the junction layer. The single membrane vesi- 
cles did not label with the anti-Cx43 antibodies for either the 
carboxyl terminus (Fig. 4  c) or amino terminus (data not 
shown). Therefore, we demonstrated localization of  the anti- 
bodies to only the gap junction structures. 
Post-embedding EM labeling of thin sections of Novikoff 
cells was performed to localize the anti-Cx extracellular do- 
main antibodies since these domains are inaccessible in gap 
junctions in whole cell preparations.  Novikoff cells were 
lightly fixed and embedded in Lowicryl at low temperatures 
to limit denaturation of the connexins and maintain reactiv- 
ity to the antibodies. Thin sections were incubated with non- 
immune serum  and  showed no  significant localization of 
gold particles at sites of cell-cell apposition (Fig. 4 d). In 
contrast, immunogold labeling of thin sections with the anti- 
Cx43 antibody directed to the second extracellular domain 
demonstrated antibody reactivity at areas of Novikoff cell- 
cell appositions (Fig. 4  e). 
Effects of  Antibody Fab Fragments on Gap 
Junction Assembly 
Novikoff  cells, which grow as aggregates of cells in suspen- 
Figure  3. Indirect immtmofiuorescence  of  Novikoffcells.  Cells were 
fixed, permeabilized, and reacted with anti-Cx43 antibodies. Little 
immunofluorescence  staining was observed with non-immune se- 
rum (a), and discrete punctate immunolabeling (arrows) was ob- 
served with both the anti-Cx43 antibodies for the amino terminus 
(AT-2, b) and carboxyl terminus (CT-360, c). Perinuclear labeling 
was observed with both the anti-Cx43 antibodies. Bar, 20 #m. 
sion culture, were dissociated with EDTA resulting in >95% 
single cells. The cells were maintained as single cells in sus- 
pension culture for 90 rain to allow recovery of  the cells from 
the EDTA treatment. We have previously demonstrated that 
when cells were dissociated and allowed to recover there 
was little retention of pre-existing gap junction structures 
(Meyer, 1991; #56) (39, 40). The cells were allowed to settle 
onto petri dishes and reaggregated for 1 h in media contain- 
ing Fab fragments made from the different antibodies. We 
then assayed for gap  junction permeability by microinjection 
The Journal  of Cell Biology,  Volume 119, 1992  182 Figure 4. (a, b, and c) Transmission electron micrographs of  Novikoff  plasma membranes treated with non-immune serum (a) or anti-Cx43 
antibody for the carboxyl terminus (b and c). The samples were then incubated with 10 nm gold anti-rabbit  IgG, fixed and embedded 
in Epon-Araidite. The non-immune serum samples contained few gold particles on the gap jtmctions (a, arrowheads)  while the gap junction 
profiles were strongly immunogold labeled with the antibody for the carboxyl terminus of  Cx43 (b, arrowheads). Single membrane vesicles 
were unlabeled with the anti-Cx43 carboxyl terminus antibody (c). (d and e) Transmission electron micrographs of thin sections of cells 
embedded in Lowicryl and immunogold labeled. The sections were incubated with non-immune serum (d) or an antibody to the second 
extracellular domain of Cx43 (e). The non-immune serum showed no gold particles at the sites of cell-cell apposition (d, arrowheads), 
In contrast, the antibody for the second extracellular domain of Cx43 labeled the site of cell-cell apposition (e, arrowheads). Bars: (a 
and b) 200 nm; (c) 170 nm; (d and e) 250 nm. 
of Lucifer  yellow into one cell of a pair. After the microinjec- 
tion experiments were completed the cell samples were fixed 
and processed for freeze-fracture and EM to assay for gap 
junction structures. 
Dye Transfer 
Control Antibodies.  Control Fab  fragments included:  (a) 
site-directed antibodies to the amino terminus of Cx43 (Fig. 
5 a); (b) site-directed antibodies to the carboxyl terminus of 
Cx43 (Fig. 5 b); (c) pre-immune serum; (d) non-immune se- 
rum; (e) a polyclonal antibody for lens MIP which did not 
recognize Novikoff  proteins in immunoblots and was used as 
an immune serum unrelated to connexins; and (f) an anti-rat 
MHC mAb which recognized a 47-kD protein in Novikoff 
cells as determined by immunoblots (data not shown). The 
anti-rat MHC Fab fragments (Fig.  5  c) were added at the 
highest protein concentration used in the experiments to de- 
termine whether simple Fab fragment binding to the cells 
was sufficient to alter gap junction assembly. We observed 
cell-cell dye transfer within 30 s after microinjection in all 
the control antibody Fab fragment treated samples. No effect 
on the percentage of  cell pairs exhibiting dye transfer was ob- 
served (Table I). 
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Cell pairs 
1-h treatment with  Fab  Cell pairs  without dye transfer 
Fab fragments*  concentration  with dye transfer  after 4 min 
Number of  Number of  Total number 
injections  Percent  injections  Percent  of injections 
~g/mO 
AT-2  250  40  95  2  5  42 
CT-360  120  10  91  1  9  11 
250  52  95  3  5  55 
MHC  250  38  91  4  9  42 
Non-immune serum  30  12  100  0  0  12 
60  8  100  0  0  8 
120  12  100  0  0  12 
250  13  100  0  0  13 
MIP  125  I1  92  1  8  12 
250  30  97  1  3  31 
Pre-Cx32  164-189  250  18  95  1  5  19 
A-CAM  125  6  60  4  40  10 
250  3  7  42  93  45 
EL-46  30  15  100  0  0  15 
60  5  12  37  88  42 
EL-186  30  7  12  52  88  59 
Cx32  164-189  60  8  100  0  0  8 
120  13  100  0  0  13 
250  6  9  60  91  66 
* AT-2, Polyclonal antibody specific for the N-terminus of Cx43.  CT-360, Affinity purified polyclonal antibody specific for the C-terminus of Cx43. MHC, 
Monoclonal to the Rat Major Histocompatibility Complex. MIP,  Polyclonal antibody to the lens main intrinsic protein. A-CAM,  mAb to the a-cell adhesion 
molecule. EL-46, Affinity purified polyclonal to the first extracellular domain of Cx43. EL-186, Affinity purified polyclonal antibody to the second extracellular 
domain of Cx43. Cx32-164-189, Polyclonal antibody to the second extracellular domain of Cx32. 
CeUAdhesion Molecule Antibody. We examined the role 
of the cell adhesion molecule, A-CAM (N-cadherin), in gap 
junction assembly. Antibodies for A-CAM (49) reacted with 
a  135-kD  protein in immunoblots of Novikoff membranes 
(data not shown). We observed no cell-cell dye transfer 4 
min after microinjection in 93 % of the cell pairs treated with 
the anti-A-CAM antibody Fab fragments added at 250/xg 
protein/ml (Fig. 5 d). The percentage of cell pairs exhibiting 
cell-cell dye transfer was dependent upon the anti-A-CAM 
Fab fragment concentration (Table I) since only 40 % of the 
cell pairs  exhibited cell-cell dye transfer at  125  #g pro- 
tein/ml. 
Antibodies to the ExtraceUular Domains of Connexins. 
We evaluated the function of the extracellular domains of 
connexins in gap junction assembly by treating the cells with 
Fab fragments of antibodies for the extracellular domains of 
connexins. The percentage of cell pairs exhibiting cell-cell 
dye transfer was dependent on Fab fragment concentration. 
We observed no cell-cell dye transfer 4 min after microinjec- 
tion between '~,90% of the cell pairs treated with Fab frag- 
ments of the antibodies for the first (Fig. 5 e) or the second 
extracellular domains (Fig. 5 f) of Cx43 at 30-60 tzg pro- 
tein/ml.  The  Fab  fragments for extracellular domains of 
Cx43, which were prepared from affinity  purified antibodies, 
only partially blocked dye transfer between cell pairs  at 
lower concentrations (Table  I).  In contrast, the Fab frag- 
ments of antibodies for the second extracellular domain of 
Cx32 (Fig. 5 g) were required at 250 t~g/ml to block cell-cell 
dye transfer. The anti-Cx32 Fab fragments were made from 
an IgG fraction collected from a protein A column but had 
not been affinity purified. 
Freeze-fracture and Electron Microscopy 
The absence of cell-cell dye transfer between 90 % of the cell 
pairs treated with Fab fragments for the extracellular domain 
Figure 5.  Phase and fluorescence photographs of cell pairs 4  rain after one cell of a pair (arrow) was microinjected with Lucifer yellow 
dye. The reaggregated cells were bathed in media containing Fab fragments of the different antibodies: a, antibody for the amino terminus 
of Cx43 (AT-2); b, antibody for the carboxyl terminus of Cx43 (CT-360); c, anti-rat MHC mAb; d,  anti-A-CAM mAb; e, antibody for 
the first extracellular domain of Cx43 (EL-46); f,  antibody for the second extracellular domain of Cx43  (EL-186); g,  antibody for the 
second extracellular domain of Cx32.  Bar, 20 #m. 
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l-h treatment  with  Fab  Interfaces  Interfaces 
Fab fragments*  Concentration  with junctions  without junctions 
Total number 
Number  Percent  Number  Percent  of interfaces 
(ug/ml) 
AT-2  250  15  50  15  50  30 
CT-360  250  13  46  15  54  28 
MHC  250  14  54  12  46  26 
Non-immune serum  250  9  45  11  55  20 
Pre-Cx32  164-189  250  16  53  14  47  30 
A-CAM  250  0  0  27  100  27 
EL-46  60  0  0  28  100  28 
EL-186  30  0  0  31  100  31 
Cx32  I64-189  250  0  0  26  100  26 
* AT-2, Polyclonal antibody  specific  for the N-terminus of Cx43. CT-360,  Affinity purified polyclonal  antibody  specific for the C-terminus  of Cx43.  MHC, 
Monoclonal to the Rat Major Histocompatibility  Complex. A-CAM, Monoclonal antibody to the a-cell adhesion molecule.  Cx32-164-189,  Polyclonal  antibody 
to the second extracellular  domain of Cx32.  EL-46, Affinity purified polyclonal  to the first extracellular  domain of Cx43.  EL-186,  Affinity purified polyclonal 
antibody to the second extracellular  domain of Cx43. 
of connexin43 or A-CAM could have been due to the closure 
of the gap junction channels or to inhibition of the assembly 
of gap junction channels. Therefore, we used freeze-fracture 
EM to assay for the presence of gap junctions in samples that 
had been used for dye microinjection. We observed normal 
appearing gap junctions and formation plaques on •50%  of 
the cell interfaces between the ceils treated with Fab frag- 
ments of  control antibodies (Table II). The control antibodies 
included pre-immune serum, non-immune serum, anti-rfit 
MHC, and antibodies for the amino and carboxyl termini of 
Cx43. Since no gap junctions were present at the start of the 
reaggregation period (33, 39, 40), the presence of gap junc- 
tion structures in the control samples indicated that gap junc- 
tion assembly had occurred (Table  II).  However,  we ob- 
served no gap junctions in samples treated with antibody Fab 
fragments for the first or second extracellular domain of 
Cx43,  the second extracellular domain of Cx32, or the cell 
adhesion molecule, A-CAM (Table II). We observed a nor- 
mai distribution of the nonjunction intramembranous parti- 
cles in all the freeze fracture samples. 
Our results suggest that the absence of cell-cell dye trans- 
fer between cells treated with Fab fragments for the extracel- 
lular domains of connexins or A-CAM was due to the inhibi- 
tion of gap junction assembly. 
Effects of  Antibody Fab Fragments on 
Membrane-Membrane Apposition 
Cell-cell adhesion could have been altered by the various an- 
tibody Fab  fragment treatments. We performed a  simple 
light  microscopic  assay  of  cell  adhesion  to  determine 
whether our  results could be explained by cell adhesion 
differences. We determined the percentages of cells present 
as singles, pairs, triplets, or clusters of four and more cells 
following cell reaggregation in the petri dish. No statistically 
significant difference among the various samples was ob- 
served (data not shown). Thus, it is unlikely that our obser- 
vations were simply due to gross changes in cell adhesion. 
We further investigated cell-cell adhesion and the degree 
of membrane-membrane apposition with transmission EM 
and morphometric analysis of thin sections. We counted an 
average of 2.8 adherens junctions per cell-cell profile be- 
tween cells treated with the Fab fragments of a control anti- 
body  (directed to  the  cytoplasmic carboxyl  terminus  of 
Cx43). An average intermembrane distance of 3 :t: 0.4 nm 
(n =  53 cell pairs) was measured in the regions of adherens 
junctions and a distance of 8  5:1.1 nm in the nonjunction 
regions (Fig. 6 a). We observed the same trends of the pres- 
ence of adherens junctions and close membrane-membrane 
apposition between cells treated with other control Fab frag- 
ments including the pre-immune serum, the anti-Cx43 amino 
terminus antibody, and the anti-rat MHC antibody (data not 
shown). 
No adberens junctions and a greater intermembrane dis- 
tance were detected between the cells treated with the anti- 
A-CAM (N-cadherin) Fab fragments. The intermembrane dis- 
tance between adjacent ceils was 32  +  1.6 nm (Fig. 6 b; 
n  =  57 cell pairs). 
We observed  no  adherens junctions between the  cells 
treated with the antibody Fab fragments for either the first 
or second extracellular domain of Cx43 or for the second ex- 
tracellular domain of Cx32.  The intermembrane distance 
between cells treated with Fab fragments of antibodies for 
the second extracellular Cx domain of Cx43 (Fig. 6 c) was 
11.0 +  1.9 nm (n =  61 cell pairs), which was similar to the 
nonjunction  intermembrane  distance  in  control  samples. 
The intermembrane distances between cells treated with Fab 
fragments for the first extracellular domain of Cx43 and sec- 
ond extracellular domain of Cx32 (data not shown) were also 
similar to the intermembrane distances for the nonjunction 
control sample. 
Treatment of  the cells with Fab fragments for either A-CAM 
or the extracellular cormexin domains blocked gap junction 
and adherens junction formation, however the modes of ac- 
tion may be different. The cells treated with the anti-A-CAM 
Fab fragments had increased intermembrane distances be- 
tween apposing cells compared to controls. In contrast, cells 
treated with Fab fragments of antibodies for the extraeellu- 
lar domains of connexins had intermembrane distances that 
were similar to the control sample nonjunction distance. 
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treated with antibody Fab fragments. Ceils treated with Fab frag- 
ments of antibodies for the carboxyl terminus of Cx43 (a) (which 
allowed dye transfer) were closely apposed (arrow) and adherens 
junctions were present (arrowheads). Ceils treated with anti-ACAM 
Fab fragments (b) were a considerable distance apart (arrow) and 
no adherens junctions were observed. Cells treated with the Fab 
fragments of antibodies for the  second extracellular  domain  of 
Cx43 (c) (which blocked cell-cell dye transfer) were only as closely 
apposed (arrow) as the nonjunction distance in the control Fab frag- 
ment treated cells (a). We observed no adherens junctions in the 
samples treated with Fab fragments of antibodies for the Cx extra- 
cellular domains (c). Bar, 55 nm. 
Discussion 
Little is known about the role the cytoplasmic and extracellu- 
lar domains of gap junction proteins play in the establish- 
ment of cell-cell communication. In this study, we examined 
the function of the extracellular domains of the Cxs in junc- 
tion assembly. Reaggregating Novikoff  cells treated with Fab 
fragments of antibodies directed against the first or second 
extracellular domains of Cxs showed inhibited cell-cell dye 
transfer. We observed no gap junctions or formation plaques 
between these cells indicating that the antibody Fab frag- 
ments prevented the assembly of gap junction structures in 
contrast to simple closure of gap junction channels. In addi- 
tion, cells treated with anti-A-CAM (N-cadherin) Fab frag- 
ments displayed inhibited cell-cell dye transfer and the ab- 
sence of gap junctions. We demonstrated that interactions of 
the extracellular domains of Cxs and cell interactions medi- 
ated by A-CAM are required for the assembly of gap junc- 
tions between reaggregated Novikoff ceils. 
We observed, unexpectedly, that adherens junction forma- 
tion was inhibited by treatment of the cells with Fab frag- 
ments of antibodies for the Cx extracellular domains. Adhe- 
rens junction assembly was also inhibited by treatment of  the 
cells with Fab fragments of antibodies for A-CAM. 
Characterization  of Novikoff Gap Junctions 
Using immunoblots we demonstrated that four different anti- 
Cx43 antibodies recognized two major bands (43 and 45 k.D) 
in Novikoff cell membranes. The 45-kD band was alkaline 
phosphatase sensitive suggesting that the antibodies recog- 
nized both phosphorylated and nonphosphorylated forms of 
the gap junction protein. The differences in antibody binding 
to the 43- and 45-kD bands that we observed were similar 
to  the  differential  immunoprecipitation  results  obtained 
when the amino and carboxyl termini antibodies were used 
to immunoprecipitate Cx43 from myocyte  cultures (27). The 
amino terminus antibody also recognized bands of '~ 29, 49, 
and 71  kD.  The 29-kD band may have been a  proteolytic 
fragment of Cx43 (54). It is not clear whether the 71-kD band 
was similar to the 70-kD gap junction protein reported in 
heart (19) or whether it and the 49-kD band represented ag- 
gregates of breakdown products and intact Cx43. The lack 
of reactivity of the 71-kD band with any of the other Cx anti- 
bodies, including those for the conserved extracellular do- 
mains, suggested that another connexin was not likely to be 
involved in our experiments. 
We showed by pre-embedding immunogold labeling that 
antibodies for the amino and carboxyl termini of Cx43 la- 
beled typical gap junction profiles as reported by others (17, 
19, 27, 46, 54, 55, 57). We used post-embedding labeling of 
cells to demonstrate localization of antibodies  for the ex- 
tracellular domains of connexins on the Novikoff  cell surface 
in  areas  of cell-cell  contact.  Previous  reports  used  pre- 
embedding methods to immunogold-label gap junctions with 
anti-Cx extracellular domain antibodies after junctions had 
been split with hyperosmotic urea or sucrose (17, 34). 
Function of the ExtraceUular Domains of Connexins 
in Gap Junction Assembly 
We examined the role of the extracellular domains of Cxs in 
gap junction assembly by treating cells with antibody Fab 
fragments. We report the first demonstration that Fab frag- 
ments  of antibodies  for the extracellular domains  of Cxs 
blocked cell-cell dye transfer and prevented the assembly of 
gap junction  structures.  Previous  reports have  shown  in- 
hibited cell-cell dye transfer after microinjection of anti-Cx 
antibodies into cells (2, 20, 29, 46, 51, 52, 54) or after load- 
ing antibodies into permeabilized cells (13).  The inhibited 
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could be due to closure of gap junction channels resulting in 
a  decrease  in gap junction permeability.  In contrast,  we 
added Fab fragments of antibodies for the extracellular do- 
mains of the Cxs to the media containing the cells and pre- 
vented gap junction assembly. The external domains, which 
are thought to protrude extraceUularly from the membrane 
(30), may participate in the initial binding and alignment of 
the connexons that results in the formation of functional cell- 
cell channels. Therefore, the antibody Fab fragments may  dis- 
turb the process of gap junction assembly by interfering with 
Cx interactions. Synthetic oligopeptides to the extracellular 
domains of Cxs have also been reported to hinder gap junc- 
tion formation (8). 
We showed that the binding of antibody Fab fragment to 
the cell surface was not sufficient to alter junction assembly 
since anti-MHC Fab fragments bound to the cells but did not 
affect junction formation. Junction assembly was only af- 
fected by Fab fragments of  antibodies for the Cx extracellular 
domains and A-CAM suggesting that these are components 
involved in junction formation. 
The only other study that has addressed the function of the 
extracellular domains of Cxs used paired oocytes expressing 
Cx32 (7).  The investigators observed altered junction per- 
meability when they treated the oocytes with thiol-specific 
reagents or when they mutated the Cx32 extracellular do- 
main cysteine residues to serine residues. The thiol reagents 
may have altered the extracellular domain cysteine residues 
or other cell surface components involved in junction assem- 
bly. The mutation of the Cx32 extracellular domain cysteine 
residues was a more direct test of the extracellular domains 
function although the study did not demonstrate that the mu- 
tated Cxs were present on the cell surface (7). 
Relationship of CeU-CeU Contact and 
Junction Assembly 
CAMs are thought to participate in selective cell-cell recog- 
nition and adhesion (1,  10,  11,  14, 42, 43, 44) and may be 
required  to  initiate  a  wide  variety  of  cell  interactions, 
Cell-ceU adhesion mechanisms are functionally divided into 
two basic systems, a calcium-independent (the neural cell 
adhesion molecule;  N-CAM)  and calcium-dependent sys- 
tems (the cadherins) (47, 50). N-CAM and the cadherins are 
large cell surface glycoproteins that are completely different 
structurally and appear to be evolutionarily unrelated (10). 
CAM interactions have been proposed to be early recogni- 
tion events between cells that are necessary for the formation 
of a variety of specialized intercellular junctions (10, 12, 18, 
31, 32, 50). 
We investigated the role of A-CAM (N-cadherin) in junc- 
tion assembly. Anti-A-CAM Fab fragments blocked cell-cell 
dye transfer and the formation of gap junction and adherens 
junction structures between reaggregating Novikoff cells. A 
previous report examined the function of N-CAM by treating 
cultures of chick neural plate cells with anti-N-CAM Fab 
fragments (25). A delay in the establishment of gap junction 
communication was  observed.  Other  investigators trans- 
fected cells with cadherin cDNAs to investigate the relation- 
ship between cadherins (calcium-dependent CAMs) and gap 
junction communication (23, 31, 32).  Several  reports have 
used S180 cells that were round or spindle shaped with few 
areas of cell-cell apposition when untransfected (31, 32). 
The cadherin cDNA transfected $180 cells formed sheets of 
epithelioid cells  with  large  areas  of cell-cell  apposition. 
Upon addition of anti-cadherin Fab fragments the epithelioid 
sheets dissociated resulting in cells with shapes resembling 
the untransfected cells and a concurrent reduction in gap and 
adherens junctions (31, 32).  These investigators proposed 
that the linkage of the cells by cell adhesion molecules was 
a necessary event for the expression of junction structures. 
Since a major change occurred in cell shape and the degree 
of cell-cell contact, the alterations in junctions that were ob- 
served could also be explained by an indirect effect of cell 
adhesion molecules on the extent and proximity of cell-cell 
contact. We observed an absence of junctions in Novikoff 
cells treated with anti-A-CAM Fab fragments without a cell 
shape  change or  light microscopically visible  change  in 
cell-cell apposition. We did observe an effect on membrane- 
membrane apposition upon further examination with thin 
section EM. We suggest that light microscopic observations 
on cell-cell apposition may not be sensitive enough to detect 
changes in the degree of membrane apposition. 
Adherens junctions represent a specialized class of cell- 
cell and cell-substrate interactions. The cell-ceU adherens 
junctions are associated with cadherins on the cell surface 
and the actin containing microfilament system and plaque 
proteins such as catenin, vinculin, plakoglobin (15, 47), and 
protein kinases (45) at the cytoplasmic surface. We unexpec- 
tedly found that adherens junction assembly was inhibited by 
treatment of the cells with the Fab fragments of antibodies 
for the extracellular domains of Cxs as well as A-CAM. Ad- 
herens junction assembly had previously only been inhibited 
by treatment of cells with anti-cadherin Fab fragments (18, 
31, 32, 50). 
We observed that cells treated with Fab fragments of anti- 
bodies for A-CAM were a considerable distance apart.  In 
contrast, the cells treated with the Fab fragments for the ex- 
tracellular domains of connexins were only as closely ap- 
posed as the nonjunction distance in control samples. The 
mechanism by which Fab fragments of antibodies for the Cx 
extraceUular  domains inhibited adherens junction formation 
is  unknown.  The anti-Cx Fab fragments could have pre- 
vented cell-cell recognition and the acquisition of the very 
close  membrane-membrane  apposition  normally  found 
within junctions. Alternatively, the antibody Fab fragments 
may have prevented transmembrane signaling and the activa- 
tion of cytoplasmic components such as protein kinases (45) 
thus interfering with adherens junction formation. Further 
experiments will be necessary to determine whether adhe- 
sion per se or the transduction of information arising from 
cell-cell interactions mediated by cell adhesion molecules is 
important for junction formation. 
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